There is growing consumer and patient demand for products containing cannabidiol (CBD) and other constituents of the cannabis plant, due to their purported medicinal benefits for a myriad of health conditions. Quality control laboratories provide important ancillary services for the medical cannabis industry in the United States. Method development for cannabis analysis is on-going in the industry due to increasing demands on laboratories to produce accurate results in a timely and inexpensive manner.
This presentation will discuss various cannabis extractions methods for producing different products, as well as the effects of sample preparation and analysis on the labeling of these product. Results from analyzing cannabis products and the accuracy of their labels will be discussed. Data from analyzing cannabis samples, extracts, and concentrates will be shared. Lastly, the role of training and 3rd party product certification for health and safety standards will be discussed as one potential solution to the public health issues facing the cannabis industry.
Learning Objectives: